These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 7862380)

  • 1. Use of GnRH agonist before hysterectomy: a cost simulation.
    Bradham DD; Stovall TG; Thompson CD
    Obstet Gynecol; 1995 Mar; 85(3):401-6. PubMed ID: 7862380
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Potential cost savings using GnRH agonists as preoperative therapy for uterine leiomyomas.
    Saltiel E
    Formulary; 1995 Sep; 30(9):532-4, 542. PubMed ID: 10161243
    [TBL] [Abstract][Full Text] [Related]  

  • 3. GnRH agonists before surgery for uterine leiomyomas. A review.
    Crosignani PG; Vercellini P; Meschìa M; Oldani S; Bramante T
    J Reprod Med; 1996 Jun; 41(6):415-21. PubMed ID: 8799917
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gonadotropin-releasing hormone agonist use before hysterectomy.
    Stovall TG; Summit RL; Washburn SA; Ling FW
    Am J Obstet Gynecol; 1994 Jun; 170(6):1744-8; discussion 1748-51. PubMed ID: 8203435
    [TBL] [Abstract][Full Text] [Related]  

  • 5. National trends and determinants of hospitalization costs and lengths-of-stay for uterine fibroids procedures.
    Becker ER
    J Health Care Finance; 2007; 33(3):1-16. PubMed ID: 19175228
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Costs and charges associated with three alternative techniques of hysterectomy.
    Dorsey JH; Holtz PM; Griffiths RI; McGrath MM; Steinberg EP
    N Engl J Med; 1996 Aug; 335(7):476-82. PubMed ID: 8672153
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Hysterectomy for benign lesions in the north of France: epidemiology and postoperative events].
    Debodinance P
    J Gynecol Obstet Biol Reprod (Paris); 2001 Apr; 30(2):151-9. PubMed ID: 11319467
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hospital cost comparison between abdominal, vaginal, and laparoscopy-assisted vaginal hysterectomies.
    Nezhat C; Bess O; Admon D; Nezhat CH; Nezhat F
    Obstet Gynecol; 1994 May; 83(5 Pt 1):713-6. PubMed ID: 8164929
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cost-effectiveness analysis of the treatment of large leiomyomas: laparoscopic assisted vaginal hysterectomy versus abdominal hysterectomy.
    Mittapalli R; Fanning J; Flora R; Fenton BW
    Am J Obstet Gynecol; 2007 May; 196(5):e19-21. PubMed ID: 17466667
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Histopathological analysis of hysterectomy specimens.
    Jha R; Pant AD; Jha A; Adhikari RC; Sayami G
    JNMA J Nepal Med Assoc; 2006; 45(163):283-90. PubMed ID: 17334416
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Usefulness of GnRH agonists in preoperative treatment of complicated uterine myomata].
    Campusano C; Zapata R; Bianchi M; Badia JI; Arteaga E
    Rev Chil Obstet Ginecol; 1993; 58(2):150-4. PubMed ID: 8209044
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hormonal therapy before surgical treatment for uterine leiomyomas.
    Moghissi KS
    Surg Gynecol Obstet; 1991 Jun; 172(6):497-502. PubMed ID: 1827931
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Laparoscopically assisted vaginal hysterectomy in a university hospital. Decreasing the need for abdominal hysterectomy and increasing resident experience in vaginal surgery.
    Fylstra DL; Carter JF
    J Reprod Med; 1996 Jul; 41(7):497-503. PubMed ID: 8829062
    [TBL] [Abstract][Full Text] [Related]  

  • 14. GnRH analogue-induced uterine shrinkage enabling a vaginal hysterectomy and repair in large leiomyomatous uteri.
    Schneider D; Golan A; Bukovsky I; Pansky M; Caspi E
    Obstet Gynecol; 1991 Sep; 78(3 Pt 2):540-1. PubMed ID: 1831252
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vaginal hysterectomy for enlarged uteri, with or without laparoscopic assistance: randomized study.
    Daraï E; Soriano D; Kimata P; Laplace C; Lecuru F
    Obstet Gynecol; 2001 May; 97(5 Pt 1):712-6. PubMed ID: 11339921
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Myomectomy after selective preoperative treatment with a gonadotropin releasing hormone analog.
    Hutchins FL
    J Reprod Med; 1992 Aug; 37(8):699-702. PubMed ID: 1432986
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Operative approaches, indications, and medical economics evaluation of 4180 cases of hysterectomy].
    Tan XJ; Lang JH; Shen K; Liu ZF; Sun DW; Leng JH; Zhu L
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2003 Aug; 25(4):406-9. PubMed ID: 12974083
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Goserelin acetate 10.8 mg plus iron versus iron monotherapy prior to surgery in premenopausal women with iron-deficiency anemia due to uterine leiomyomas: results from a Phase III, randomized, multicenter, double-blind, controlled trial.
    Muneyyirci-Delale O; Richard-Davis G; Morris T; Armstrong J
    Clin Ther; 2007 Aug; 29(8):1682-91. PubMed ID: 17919549
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hysterectomy rates for benign indications.
    Jacobson GF; Shaber RE; Armstrong MA; Hung YY
    Obstet Gynecol; 2006 Jun; 107(6):1278-83. PubMed ID: 16738152
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Leuprolide acetate treatment and myoma arterial size.
    Rutgers JL; Spong CY; Sinow R; Heiner J
    Obstet Gynecol; 1995 Sep; 86(3):386-8. PubMed ID: 7651647
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.